MedicarePartD.guide

A non-government resource built from CMS public data

Wezlana on BlueCross Rx Value (S5953-001)

ustekinumab-auub

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 3 per 84 days.

$6,982.03
Patient pays / month, after deductible
$7,443.28
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

WEZLANA 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $27,928.11 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
WEZLANA 45 mg/.5mL Injection, Solution5$6,982.03PA · 3 per 84 days
WEZLANA 45 mg/.5mL Injection, Solution5$6,982.03PA · 3 per 84 days
WEZLANA 90 mg/mL Injection, Solution5$6,982.03PA · 3 per 84 days

Other IL-17 and IL-23 biologics on this plan

Verify with the plan before prescribing or filling. Member services: (888)645-6025. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5953-001